• By ICR Secretariat
  • Posted Thursday, September 8, 2022

Pfizer shifts oncology chief Schmeltz to new strategy role as rare disease head Varma fills in


Executive reshuffling continues at Pfizer.

After four years as global president of Pfizer oncology, Andy Schmeltz is moving into a new role as senior vice president of commercial strategy and innovation, the 19-year Pfizer veteran announced in a  LinkedIn post.